Printer Friendly

Aspartame: Soffritti responds.

As communicated in his letter, Abegaz represents Ajinomoto Corporate Services LLC. Ajinomoto, which holds 45% of the market share for worldwide aspartame production (Ajinomoto 2006), is well known for its aggressive and effective defense of its commercial interests. The action by Abegaz to reproduce portions of the opinion issued by the European Food Safety Authority (2006) regarding the results of our long-term carcinogenesis bioassay on aspartame (Soffritti et al. 2006) is clearly specious.

The author declares he has no competing financial interests.

Morando Soffritti

European Foundation of Oncology and Environmental Sciences "B. Ramazzini" Cesare Maltoni Cancer Research Center

Bologna, Italy



Ajinomoto Co., Inc. 2006. First Quarter-FY2006 Market and Other Information. Available: [accessed 29 September 2006].

European Food Safety Authority. 2006. Opinion of the Scientific Panel AFC Related to a New Long-term Carcinogenicity Study on Aspartame. Parma, Italy: European Food Safety Authority. Available: [accessed 29 September 2006].

Soffritti M, Belpoggi F, Esposti DD, Lambertini L, Tibaldi E, Rigano A. 2006. First experimental demonstration of the multipotential carcinogenic effects of aspartame administered in the feed of Sprague-Dawley rats. Environ Health Perspect 114:379-385.
COPYRIGHT 2007 National Institute of Environmental Health Sciences
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Correspondence
Author:Soffritti, Morando
Publication:Environmental Health Perspectives
Date:Jan 1, 2007
Previous Article:Aspartame not linked to cancer.
Next Article:Children's health/regional collaboration to reduce lead exposure in children.

Related Articles
How sweet it isn't? Natural alternatives to sugar, minus the calories and carcinogens.
Aspartame & cancer.
Not so sweet: cancers in rats that consumed aspartame.
Aspartame-induced Sjogren syndrome.
Sour finding on popular sweetener: increased cancer incidence associated with low-dose aspartame intake.
First experimental demonstration of the multipotential carcinogenic effects of aspartame administered in the feed to Sprague-Dawley rats.
Aspartame not linked to cancer.
Testing needed for acesulfame potassium, an artificial sweetener.
Acesulfame potassium: Soffritti responds.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters